📰 Key Takeaways

The US government is implementing case-by-case review controls on frontier AI model releases, with the impact spreading from Anthropic to OpenAI. Following the government’s halt of Anthropic’s Fable and Mythos models, OpenAI’s latest GPT 5.6 faces the same fate — according to The Information, the model only has access to limited preview, requiring individual government approval for client access before formal release can be considered. Altman estimates the preview period will be “a few weeks,” but Mythos has been stuck in review for months with no sign of a formal launch. Every additional week of review delay directly eats into the commercial returns of new models that AI labs have invested heavily in, and could also slow down data center construction investment schedules.

It’s worth noting that OpenAI and Anthropic are now in exactly the same situation — the industry narratives about “Anthropic playing regulatory capture” or “OpenAI cozying up to Trump to squash competitors” seem too narrow in the face of this structural crisis. The real core issue is: the government currently lacks the technical capability to perform the required safety testing, and hasn’t clearly articulated what specific risks need to be prevented.

However, the article emphasizes that the regulatory impulse isn’t entirely baseless. There are genuine concerns worth taking seriously in AI tools around cybersecurity, biological risks, and model alignment. Dean Ball from George Mason University points out that simply restricting release isn’t the solution — the real effective path forward requires the government, labs, and research community to work together on building a review process that’s both actionable and risk-targeted, rather than the current directionless temporary regulation.

💬 JudyAI Lab Perspective

The US government is regulating frontier AI models through case-by-case review, affecting both Anthropic and OpenAI — this is no longer a political game for individual companies, but a structural regulatory new normal for the entire AI industry, which deserves our close attention.

For the AI builder community, this case exposes a risk that’s been underestimated: regulatory timelines have become a real variable in commercial planning. GPT 5.6 only has limited preview access, Mythos has been stuck for months — every week of review delay directly eats into the commercial return window for new models, and could slow down the entire downstream ecosystem’s pace. The more fundamental困境在于，政府目前既缺乏执行安全测试的技术能力，也未能说清楚真正要防范的具体风险，让整个审查流程既不透明也难以预期。The fundamental problem is that the government currently lacks the technical capability to perform safety testing and hasn’t clearly articulated what specific risks need to be prevented, making the entire review process neither transparent nor predictable. Previous industry narratives about “who’s cozying up to regulators” or “who’s suppressing competitors” have lost their explanatory power in the face of this structural issue — Anthropic and OpenAI being in exactly the same situation is the best proof.

If your product heavily relies on a specific frontier model, now is the time to think about backup routes: when the core model is delayed by months, can your plans still move forward?

📅 Original Info

🔗 Further Reading